PRODUCT OPPORTUNITY EVALUATION AND MAXIMISATION

We can help your business to:
  • Scan the landscape of opportunities – as asset owners or investors
  • Plan a path to market for assets in early development
  • Assess commercial viability and valuation of assets
  • Undertake effective due diligence on assets and data

For assets in the preclinical to Phase 2 space evaluating the opportunity and planning the best development path to patient and market becomes a priority. The Phetairos POEM group can help to maximise the value of assets by providing an integrated view of the therapeutic area landscape, the competition, the development options and challenges, the regulatory path, and commercial considerations and risks. Additionally for those looking to acquire or license assets we can provide Due Diligence services with full valuation, deal terms, and legal and IP guidance.

Let's talk!
GET IN TOUCH

Would you like to discuss a collaboration?
Please get in touch with us at projects@phetairos.com or +49 172 6340202 or post a project.



Claude Houet
Director

POST A PROJECT
Post a Project
By using this form you agree to our privacy policy.